Join Dr. Kerry Hughes, technical leader from Almac, for a presentation on the application of NMR in GMP settings to ensure high-quality performance of drug discovery workflows.
The use of Nuclear Magnetic Resonance (NMR) in GMP settings is extremely valuable: when applied correctly it helps to confirm the identity, strength, quality and purity of drug products and plays a key role in the production of reproducible drug discovery workflows.
In this webinar sponsored by Bruker BioSpin, Dr. Kerry Hughes, Technical Leader at Almac, discusses the convenience of utilizing NMR during various stages of the drug development process. She also reviews the importance of instrumentation qualification and routine performance checks, and shares specific examples of how Almac is using NMR to meet GMP regulations.
Key Topics Include:
- The versatility, convenience and accessibility of NMR
- NMR in a GMP environment requires qualification and controls to ensure continued high-quality performance
- Using NMR for supplier qualification, method validation, quantification of residual solvents and full structural elucidation of small molecules and peptides
- How Almac is using the Bruker 400 AVANCE with QNP probe and 500 AVANCE NEO with prodigy cooled CryoProbe in its GMP setting
Presenters
Technical Leader
Almac
Dr Kerry Hughes is technical leader and NMR senior analytical chemist at Almac in Craigavon, County Armagh in Northern Ireland. Kerry has been working for the Almac group for four years. Before this, she completed a PhD in medicinal and pharmaceutical chemistry at Queen’s University in Belfast.
Production Partner
Bruker Corporation
Bruker offers preclinical imaging solutions for a broad spectrum of application fields, such as cancer research, neuroimaging and cardiac disease.
Additional Content From Bruker Corporation
Unlocking Your Clinical Understanding of Post-Acute COVID Syndrome (PACS), Patient Recovery, and Risk of Subsequent Disease
Watch this webinar to learn about the metabolic changes during COVID-19 disease, how these can be accurately tracked and how NMR can improve the clinical understanding of Long-COVID.
Cardiac PET/MR Imaging in Small Rodents
Experts provide a comprehensive overview of approaches to address cardiac and respiratory gating in PET and MRI in rodent models.
SmartDriveNMR – The Next Generation of Automation
Bruker experts provide an overview of SmartDrive with a particular focus on the exciting new features. They offer practical examples and demonstrate the newest features and functions live!
Related Content
Not All IBD Models Are Created Equally – How Differences Between Experimental IBD Models Can Impact Your Drug Development Program
Experts discuss differences between animal models of IBD and highlight the advantages of using immune cell-induced and spontaneous mouse models of colitis for drug development.
APS Physiology in Disease Modeling and Drug Development Roundtable
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.
The 3D DILI Model of Success – from Biological Relevance to Industry Application
Dr. Anna Borgström and Dr. Frauke Greve present the latest advancements in hepatic safety assessment using 3D liver spheroids.